LYB vs SUPN · P/E 21, rev $16.37B vs rev $426.8M
LyondellBasell Industries NV (LYB) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the LYB and SUPN stock pages for the full models.
Not investment advice.